{reportSlug=global-neisseria-gonorrhoeae-infections-treatment-market, reportId=49182, mktKeyword=Neisseria Gonorrhoeae Infections Treatment, cagr=0.00, publishDate=Dec 2020, priceOption2=6800, reportTitle=Neisseria Gonorrhoeae Infections Treatment Comprehensive Study by Type (Cribrostatin-6 , Dalbavancin , Debio-1453 , Gepotidacin Mesylate , Others), Patient Type (Gonorrhea treatment in adults, Gonorrhea treatment for partners, Gonorrhea treatment for babies), Drugs (Erythromycin, Clarithromycin, Azithromycin, Roxithromycin, Others), Adminstration (Oral, Injectable), End User (Clinic , Hospital , Others) Players and Region - Global Market Outlook to 2025, baseYr=2021, totalTableFig=200, priceOption1=3750, forecastYr=2027, noOfPages=246, reportKey=48876, breadcrum=Global Neisseria Gonorrhoeae Infections Treatment}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Dec 2020 246 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales